Positive ultrasound-guided lymph node needle biopsy in breast cancer may not mandate axillary lymph node dissection
Annals of Surgical Oncology Sep 21, 2017
Harris CK, et al. - This research explored the role of positive ultrasound (US)-guided lymph node needle biopsy in breast cancer in axillary lymph node (LN) dissection. N1 disease was reported in more than half of patients without palpable adenopathy but with preoperative US-guided biopsy proven axillary LN metastases. For patients presenting with both tumor size ≤2 cm and only 1 abnormal LN on axillary ultrasound (axUS), 73% appeared to have N1 disease. Such patients could attempt at sentinel LN biopsy (SLNB) if they were otherwise analogous to Z11 patients.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries